1. Durvalumab consolidation in patients with unresectable stage III non-small cell lung cancer with driver genomic alterations. (May 2022) Authors: Riudavets, Mariona; Auclin, Edouard; Mosteiro, Miguel; Dempsey, Naomi; Majem, Margarita; Lobefaro, Riccardo; López-Castro, Rafael; Bosch-Barrera, Joaquim; Pilotto, Sara; Escalera, Elena; Tagliamento, Marco; Mosquera, Joaquin; Zalcman, Gerard; Aboubakar-Nana, Frank; Ponce, Santiago; Dal Maso, Ales... Journal: European journal of cancer Issue: Volume 167(2022) Page Start: 142 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗